Nov 9 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY
SHAREHOLDERS
BASIC AND DILUTED $0.34
* ANTICIPATES CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO
FUND
PLANNED OPERATIONS INTO SECOND HALF OF 2023
* Q3 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9FF2hR
Further company coverage: 698Y.F
((Reuters.Briefs@thomsonreuters.com;))